Actieve functies van Greg Mann
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| NKARTA, INC. | Investor Relations Contact | 01-02-2020 | - |
| Public Communications Contact | 01-02-2020 | - |
Loopbaan van Greg Mann
Eerdere bekende functies van Greg Mann
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Abgenix, Inc.
 Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | Investor Relations Contact | - | 01-01-2006 |
| KITE PHARMA INC | Investor Relations Contact | 01-01-2016 | - |
| Public Communications Contact | - | - | |
| FIBROGEN, INC. | Investor Relations Contact | 01-03-2013 | - |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Investor Relations Contact | 4 |
| Public Communications Contact | 2 |
Sectoraal
| Health Technology | 5 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| FIBROGEN, INC. | Health Technology |
| NKARTA, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Abgenix, Inc.
Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | Health Technology |
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
